Evaluation of the Efficacy, Safety, and Tolerability of LevoCept

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,525

Participants

Timeline

Start Date

June 1, 2026

Primary Completion Date

June 1, 2030

Study Completion Date

June 1, 2032

Conditions
ContraceptionWomen at Risk for Pregnancy
Interventions
DRUG

LevoCept

Levonorgestrel-Releasing Intrauterine System

Trial Locations (27)

10032

Columbia University Medical Center, New York

15213

Magee-Womens Hospital, Center for Family Planning Research, Pittsburgh

19104

Hospital of the University of Pennsylvania, Philadelphia

19114

Clinical Research of Philadelphia, LLC, Philadelphia

23502

Tidewater Physicians for Women, Norfolk

23507

Eastern Virginia Medical, Norfolk

30034

Soapstone Center for Clinical Research, Decatur

30308

Emory University School of Medicine Gynecology/Obstetrics, Atlanta

43209

Ohio State University, Columbus

43210

The Ohio State University Ob/Gyn Research Office, Columbus

45267

University of Cincinnati/Reproductive Medicine Research, Cincinnati

46202

IU Health University Hospital, Indianapolis

55408

Planned Parenthood North Central States, Minneapolis

63088

Planned Parenthood of the St. Louis Region and Southwest Missouri, Manchester

77030

Advances In Health, Houston

80045

University Of Colorado Department of Obstetrics & Gyncology, Aurora

84132

University of Utah Healthcare Health Sciences Center, Salt Lake City

89128

Rex Garn Mabey Jr., MD, Las Vegas

90010

Essential Access Health-Los Angeles, Los Angeles

92108

WR-Medical Center for Clinical Research, San Diego

92111

Women's Health Care Research, San Diego

94305

Stanford University, Medical Center, Obstetrics and Gynecolocy, Stanford

94710

Essential Access Health-Berkeley, Berkeley

95817

University of California Davis Health System Department of Obstetrics and Gynecology, Sacramento

96826

University of Hawaii, Honolulu

97239

Oregon Health & Science University, Portland

98105

Seattle Women's: Health, Research, Gynecology, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

Sebela Women's Health Inc.

INDUSTRY